inHEART Revenue and Competitors
Estimated Revenue & Valuation
- inHEART's estimated annual revenue is currently $3.8M per year.
- inHEART's estimated revenue per employee is $112,000
Employee Data
- inHEART has 34 Employees.
- inHEART grew their employee count by 0% last year.
inHEART's People
Name | Title | Email/Phone |
---|---|---|
1 | Senior Consultant, US Market Development | Reveal Email/Phone |
inHEART Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.3M | 4 | N/A | N/A | N/A |
#2 | $3.4M | 30 | 7% | N/A | N/A |
#3 | $27M | 175 | 26% | N/A | N/A |
#4 | $7.7M | 61 | 0% | N/A | N/A |
#5 | $175.6M | 877 | -6% | $91.2M | N/A |
#6 | $1.5M | 18 | -5% | N/A | N/A |
#7 | $2M | 20 | N/A | N/A | N/A |
#8 | $0.2M | 3 | -70% | N/A | N/A |
#9 | $32M | 208 | 41% | N/A | N/A |
#10 | $1.3M | 16 | -33% | N/A | N/A |
What Is inHEART?
inHEART is a spin-off from IHU Liryc and Inria that combines their top-tier expertise in cardiac electrophysiology and medical imaging to develop advanced medical imaging processing and visualization solutions for heart rhythm disorders.
keywords:N/AN/A
Total Funding
34
Number of Employees
$3.8M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
inHEART News
Vaccination Cuts Severe COVID-19 Risk in Heart Transplant Patients. COVID-19 vaccination is not associated with heart transplant-specific...
In this video, Lynne Warner Stevenson, MD, professor of medicine at Vanderbilt University Medical Center, discusses new HF developments...
The inHEART solution aims to address many of the challenges of conventional VT ablation with its proprietary segmentation algorithm that...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.3M | 34 | 3% | N/A |
#2 | $5.7M | 49 | N/A | N/A |
#3 | N/A | 64 | -12% | N/A |
#4 | $16.5M | 68 | -13% | N/A |
#5 | $12.7M | 82 | 34% | N/A |